PZ-1818

N/A

Report date: 2025/01/26 16:16:52
NME

Base Information

Drug NamePZ-1818
Drug Alias Namedual 5-HT6 receptor inverse agonist/monoaminooxydase-B inhibitor (Jagiellonian University Medical College/Maj Institute of Pharmacology/Université de Montpellier)PZ-1818
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor inverse agonistsMonoamine oxidase B inhibitors
TargetsSerotonin 6 (5-HT6) receptorMonoamine oxidase B
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJagiellonian University Medical College
China Registration ClassN/A

Develop Information

Active CompaniesJagiellonian University Medical CollegeInstytut Farmakologii Polskiej Akademii NaukUniversity of Montpellier
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A